BIOFORCE NANOSCIENCES HOLDINGS, INC.
OTC · CIK 0001310488 · Fiscal year end 1231
Latest reported period: Latest published period
Net Income
$-102,411
Eps Basic
0
Eps Diluted
0
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Net Income | $-102,411 | - | - |
| Eps Basic | 0 | - | - |
| Eps Diluted | 0 | - | - |
| Cash And Equivalents | $6,347 | - | - |
| Total Assets | $6,347 | - | - |
| Total Liabilities | $727,301 | - | - |
| Shareholders Equity | $-720,954 | - | - |
| Operating Cash Flow | $7,088 | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | BIOFORCE NANOSCIENCES HOLDINGS, INC. | 2026-05-19 | 0001091818-26-000077 |
| 10-K | BIOFORCE NANOSCIENCES HOLDINGS, INC. | 2026-04-15 | 0001091818-26-000047 |
| 10-Q | BIOFORCE NANOSCIENCES HOLDINGS, INC. | 2025-11-19 | 0001091818-25-000163 |
| 10-Q | BIOFORCE NANOSCIENCES HOLDINGS, INC. | 2025-08-11 | 0001091818-25-000091 |